Allos Therapeutics' PIPE - III Round

Allos Therapeutics raised a round of funding on March 22, 2005.

Allos Therapeutics is a biopharmaceutical company focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company's lead product candidate, pralatrexate (PDX) i…

Articles about Allos Therapeutics' PIPE - III Round: